betulinic acid has been researched along with Alloxan Diabetes in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chao, X; Chen, C; Huang, H; Huang, J; Wang, S; Xiong, F; Yang, Z | 1 |
Ahn, YM; Choi, ES; Han, BH; Kang, DG; Kho, MC; Kim, HY; Lee, HS; Lee, YJ; Park, JH; Yoon, JJ | 1 |
2 other study(ies) available for betulinic acid and Alloxan Diabetes
Article | Year |
---|---|
Betulinic acid ameliorates experimental diabetic-induced renal inflammation and fibrosis via inhibiting the activation of NF-κB signaling pathway.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; beta-Arrestin 2; Betulinic Acid; Cells, Cultured; Diabetes Mellitus, Experimental; Gene Expression Regulation; Glucose; I-kappa B Proteins; Kidney; Mesangial Cells; NF-kappa B; Pentacyclic Triterpenes; Rats; Signal Transduction; Streptozocin; Triterpenes | 2016 |
Protective effect of betulinic acid on early atherosclerosis in diabetic apolipoprotein-E gene knockout mice.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Betulinic Acid; Blood Glucose; Diabetes Mellitus, Experimental; Gene Knockout Techniques; Hyperlipidemias; Hypertension; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Pentacyclic Triterpenes; Triterpenes | 2017 |